Check often for updates.

  • Last update 6/05/2020
  • We check instructions to identify any explicit prohibitions on applications from US academic institutions but
  • We do not enter the application system or communicate with funders to confirm details.
Newest Additions (Week of 6/01/2020)

Directory:

National Institutes of Health Funding Opportunities
Other Federal Funding Opportunities
Foundations and Other Funding Opportunities
Challenges & Innovation Accelerator Competitions
Other COVID Funding Compilations

We update most items daily and also crowd-source information to aim for comprehensive representation of opportunities for those in US academic settings with breadth of disciplines. These are cross-checked weekly.

For details about the funding sources and compilations for which we conduct scheduled surveillance for funding opportunities, this is the working document enumerating sources and links: bit.ly/34HBOt8

Please suggest additions of funding opportunities in comments.

National Institutes of Health

General Communications for Awardees & Those Submitting Grants

NIH Administrative Supplements:

If you currently have an active NIH grant, you may be eligible to apply for an administrative supplement to support COVID-19 research. Administrative supplements are non-competing awards that provide additional funding to a currently funded grant to meet increased costs that are within the scope of the approved project. Contact program official to discuss. Parent funding opportunity is PA-18-591.

NIH Competitive Revisions:

Provide a path for an existing grant award to shift research priorities using the NIH Urgent Award Mechanism for a Public Health Crisis. The Urgent Award FOA (PA-18-935) enables a quick response to urgent public health needs. 

Common Fund – Office of Strategic Coordination

Notice of Special Interest: Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling through June 19, 2020
  • Funding: Not to exceed annual amount of current award
  • Project period: up to 1 year
  • Purpose: To seek new, innovative perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally.
  • Eligibility Notes: For D43, DP2, DP5, DP7, R01, R24, R25, R35, U01, U18, U19, U24, U2C, U2R, U42, U54, UG3, UH2, UH3, and UM1 awards
NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)
  • Due: September 4, 2020
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To fund new perspectives and approaches to the prevention of, preparation for, or response to coronavirus SARS-CoV-2, domestically or internationally. Any relevant area of coronavirus SARS-CoV-2 research is welcome, including behavioral/social science research, research on health disparities, novel therapeutics. Innovation may be technological or conceptual.
NIH Director’s Emergency Early Independence Awards (DP5 Clinical Trial Optional)
  • Due:
  • Funding:
  • Project period:
  • Purpose: To supports exceptional junior investigators who wish to pursue independent research without the traditional post-doctoral training period. This call is for projects related to the COVID-19 public health emergency. Innovation may be technological or conceptual.
  • Eligibility Notes: Up to 2 applicants per institution.

Office of the Director

Notice of Special Interest: Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp – Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19)-related Research
  • Due: June 22, 2020
  • Funding: Up to $200,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To support COVID-related scientific questions aligned with the currently active grant that require time-sensitive support.

Multiple NIH Institutes & Offices

(NIMHD, NIA, NIDA, NCI)
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)
  • First due date: October 5, 2020 (LOI Sept 4, 2020)
  • Funding: Not specified
  • Project period: Up to 5 years
  • Purpose: To support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. COVID-19 is one example disaster.
(OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI, NICHD, NINR, ODP, ORWH)
Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus & the Behavioral and Social Sciences
  • Due: Rolling through March 31, 2021
  • Funding: $100,000 direct costs per year
  • Project period: Up to 2 years
  • Purpose: To encourage supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.
(NIA, NIAA, NICHD, NIDA, NIMH, NINDS, NINR, NIMHD, NCCIH)
Notice of Additional Due Date and Areas of Focus of “Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)”
  • Due: June 8, 2020 and March 17, 2021
  • Funding: Not specified.
  • Project period: Up to 5 years
  • Purpose: To add June 8, 2020, due date and specific interest in COVID-19 responses. To model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing.
(NCI, NCATS, NCCIH, NHGRI, NHLBI, NIA, NIAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, ORWH, OBSSR, ODP, ECHO)
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives
  • Due: Full opportunity expected June 8, 2020
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To reduce COVID-19 associated morbidity and mortality disparities for those vulnerable and underserved populations that are disproportionately affected by, have the highest infection rates of, and/or are most at risk for adverse outcomes from contracting the virus. 
(NIMHD, NIA, NICHD, NIDCD, NIDCR, NIDA, NIEHS, NIMH, NINR, NCCIH)
Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
  • Due: Full opportunity expected June 22, 2020
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To evaluate community interventions testing 1) impacts of mitigation strategies to prevent COVID-19 transmission in health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, sociocultural, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

National Cancer Institute (NCI)

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis
Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence
  • Due: anticipated call released June 10, 2020
  • Funding: Up to $1.5M per year for U54; up to $500,000 per year for U01
  • Project period: Not specified
  • Purpose:  To characterize the immune responses elicited by SARS-CoV-2 viral infection, understand the mechanisms driving the serological, humoral and cellular immune responses, and determine the serological correlates with disease pathogenesis and protection against future infection, especially as it relates to cancer patients.
  • Notes: Applications will be U54 and U01 (Clinical Trial Not Allowed)
Notice of Special Interest: Urgent Competitive Revision & Administrative Supplements on Coronavirus Disease
  • Due: Rolling through June 25, 2020
  • Funding: Limit $100,000 direct costs
  • Project period: Generally limited to 1 year
  • Purpose:  To understand the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer.
Notice of Special Interest: Competitive Revision SBIR/STTR Supplements on Coronavirus Disease
  • Due: Rolling through June 25, 2020
  • Funding: Varies by grant type
  • Project period: Generally limited to 1 year
  • Purpose: To accelerate the development of promising technologies, the NCI encourages applications from small businesses with NCI-funded active SBIR/STTR awards for technologies that have a strong potential to be adapted/repurposed for use as a prophylactic, therapeutic or diagnostic tool for SARS-CoV-2 (COVID-19).

National Center for Advancing Translational Sciences (NCATS)

Notice of Special Interest: Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address COVID-19 Public Health Needs
  • Due: Rolling through November 10, 2020
  • Funding: Varies by FOA
  • Project period: 1 year; up to 2 years with strong justfication
  • Purpose: To highlight need for addressing COVID-19 public health emergency within existing CTSA institutions. Specific focus varies by FOA.
Limited Competitions (UL1/U01/U24/R21) to current CTSA awardees to address COVID-19 public health needs
  • Due: Variable May 2020 through July 2021
  • Purpose: NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. 
Repurposing Existing Therapeutics to address COVID-19 (UG3, UH3, U34, U01)
  • Due: Variable due dates in June and October 2020
  • Purpose: NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. 
Notice of Special Interest: Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
  • Due: Rolling May 15, 2020 through January 25, 2022
  • Project period: 1 year
  • Purpose: NCATS is especially interested in research on the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advancing the translation of research findings into diagnostics, therapeutics, and vaccines.
Notice of Special Interest: Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
  • Due: Rolling May 15, 2020 through January 25, 2022
  • Purpose: NCATS is especially interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines.

National Center for Complimentary and Integrative Health (NCCIH)

Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling through August 17, 2020
  • Funding: Up to $150,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To rapidly establish scientific evidence and/or elucidate the mechanism of action of natural product–based remedies for SARS-CoV-2 and COVID-19. For active NCCIH grants.
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)
  • Due: Rolling through October 6, 2020
  • Project period: Up to 2 years
  • Purpose: Specific interest in research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.

National Heart, Lung, & Blood Institute (NHLBI)

Notice of Special Interest: Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials
  • Due: Rolling through October 5, 2020
  • Funding: Not specified
  • Project period: Up to 2 years
  • Purpose: To leverage existing clinical trials expertise and, using NHLBI programs that are actively conducting Phase I-III clinical trials, to rapidly initiate and conduct Phase I-Phase I/II (bridging) clinical trials in patients at risk for SARS-CoV-2 infection and/or patients with COVID-19.

National Institute of Allergy & Infectious Diseases (NIAID)

NIAID COVID-19 research priorities
Notice of Special Interest: Emergency Competitive Revisions for Research on SARS-CoV-2 and COVID-19
  • Due: Rolling until March 25, 2021
  • Funding: Not more than annual amount of current parent award
  • Project period: 2 years
  • Purpose: To focus research on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19.
Notice of Special Interest: Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
  • Due: Standard dates until September 8, 2021
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To rapidly improve our understanding and available control measures for SARS-CoV-2 and COVID-19, including viral infection, replication, pathogenesis, and transmission; evolution and emergence of SARS-CoV-2 viruses; SARS-COV-2 therapeutic candidates; and more.
  • Note: Uses R03 (Clinical Trial Not Allowed), SBIR [R43/R44] (Clinical Trial Not Allowed), and Parent STTR [R41/R42] (Clinical Trial Not Allowed) mechanisms.
Partnerships for Countermeasures against Select Pathogens (R01 clinical trials not allowed)
  • Due: June 29, 2020
  • Funding: $750,000 per year; additional $300,000 can be requested in year 1
  • Project period: Up to 5 years
  • Purpose: To support milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases. Applications must include a Product Development Strategy and demonstrate substantive investment by at least one industrial participant.
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)
  • Due: Rolling through April 30, 2021
  • Funding: Up to $275,000 total costs
  • Project period: 2 years
  • Purpose: To provide an expedited funding mechanism for research on SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19). 
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
  • Due: Rolling through April 30, 2021
  • Funding: Not specified
  • Project period: up to 5 years
  • Purpose: To provide an expedited funding mechanism for research on SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19).

National Institute of Biomedical Imaging & Bioengineering (NIBIB)

Notice of Special Interest: Small Business Research & Development of Biomedical Technologies for COVID-19
  • First due date: April 5, 2020
  • Purpose: To highlight urgent need for accelerating development, translation, and commercialization of technologies to address COVID-19. Seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years. 
Notice of Special Interest: Development of Biomedical Technologies for COVID-19 
  • Due: Varied by award type (R01, R21, and R03)
  • Purpose: To highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address COVID-19. Seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years. 
Notice of Special Interest: Emergency Competitive Revision & Administrative Supplements on Biomedical Technologies for COVID-19 
  • Due: Rolling through November 10, 2020
  • Project period: 1 to 2 years
  • Purpose: To highlight urgent need for accelerating the development, translation, and commercialization of technologies to address COVID-19. Seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years.
Rapid Acceleration of Diagnostics (RADx) – Fast-Track Program for COVID-19 Test Development and Distribution
  • Due: Rolling
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to  clinical laboratory tests, that can directly detect SARS-CoV-2. NIBIB will support the full range of product development including commercialization and product distribution.
  • Notes: Uses NIH Point-of-Care Technology Research Network. Apply through RADx portal.

National Institute of Dental and Craniofacial Research (NIDCR)

NIDCR has issued FAQs for the following Notices.
Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR
  • Due: June 1, 2020 and November 2, 2020
  • Funding: Not to exceed $150,000 direct costs
  • Project period: 1 year
  • Purpose: To fund topics of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices. Topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Topics addressing influence and interaction of sex (a biological variable) and gender, race and ethnicity, and those addressing questions about risk, prevention, and health outcomes are also of interest.
Notice of Special Interest: Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network
  • Due: June 1, 2020 and November 2, 2020
  • Funding: Not specified
  • Project period: 1 year
  • Purpose: To fund topics of immediate and high impact to protect and ensure the safety of personnel and patients in dental practices, prevent SARS-COV-2 transmission, and improve detection and diagnosis of COVID-19. Successful X01 applicants will be given access to the National Dental PBRN infrastructure to support an individual project.

National Institute of Environmental Health Sciences (NIEHS)

Notice of Special Interest: Support for Understanding the Impact of Environmental Exposures on COVID-19 
  • Due: Monthly, May 1, 2020 through May 3, 2021
  • Project period: 1 year
  • Purpose: To promote rapid understanding of the potential contributions of current and past exposure to environmental agents that may exacerbate COVID-19 susceptibility, disease severity, and progression.
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)
  • Due: Monthly through October 4, 2022
  • Project period: 2 years
  • Purpose:  To understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad. Entire cycle, from submission to award, is expected to be within 3-4 months. Use this mechanism if you are applying for a new R21 grant that does not build off of an existing NIEHS grant.

National Institute of General Medical Sciences (NIGMS)

Guidance for Cost-Related Flexibilities for SCORE Award Recipients Affected by COVID-19
Notice of Special Interest: Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes
  • Due: June 18, 2020
  • Funding: Up to $400,000 direct costs
  • Project period: Up to 1 year
  • Purpose:  To create a registry of COVID-19 patients across IDeA states that includes a comprehensive set of deidentified clinical data elements.
  • Eligibility Note: Must be an active IDeA-CTR (U54) award.
Notice of Special Interest: Emergency Competitive Revisions for Research on SARS-CoV-2 and COVID-19
  • Due: Rolling through February 5, 2021
  • Funding: Not more than amount of current parent award
  • Project period: 1 year
  • Purpose: To attract Competitive Revisions to active grants to address only: 1) Incorporation of data related to SARS-CoV-2 into ongoing predictive modelling efforts for spread of SARS-CoV-2 and other related infectious agents; 2) Repurposing or modifying diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only); 3) Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only).

National Institute of Mental Health (NIMH)

Notice of Special Interest: Administrative Supplements and Revision Supplements on COVID-19
  • Due: Rolling through May 1, 2021
  • Project period: 1 year, with possible second year
  • Purpose: To examine how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or worsening mental health needs and/or suicide risk in midlife and older age adults will be seen as a high priority.
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Mental Health Research on 2019 Novel Coronavirus
  • Due: Rolling through April 15, 2021
  • Purpose: To provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest

National Institute of Minority Health & Health Disparities (NIMHD)

Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health & Health Disparities
  • First due date: May 1, 2020
  • Project period: 1 year, with possible second year
  • Purpose: To highlight urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations.

National Institute of Neurological Disorders and Stroke (NINDS)

Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
  • Due: Rolling through April 14, 2021
  • Funding: Up to $200,000 direct costs
  • Project period: Up to 1 year
  • Purpose: To highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects on the nervous system of its causative agent, SARS-CoV-2. 

National Institute on Aging (NIA)

Notice of Special Interest: Administrative Supplements & Revision Supplements on COVID-19
  • Due: Rolling until May 1, 2021
  • Funding: Not specified
  • Project period: 1 year, with possible second year
  • FAQs here: NOT-AG-20-031
  • Purpose: To support mission critical areas of research for NIA as they relate to the COVID-19 pandemic. Research interests are provided by the Division of Aging Biology, Division of Neuroscience, and the Division of Behavioral and Social Research.
Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Research on Stress Management in Relation to COVID-19
  • Due: Rolling through October 6, 2020
  • Project period: Up to 2 years
  • Purpose: To address the specific needs and circumstances of midlife and older adults, including, but not limited to, individuals with Mild Cognitive Impairment, Alzheimer’s disease and Alzheimer’s disease related dementias and their healthcare providers and caregivers.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest: Administrative Supplements & Urgent Competitive Revisions for Research on Stress Management COVID-19
  • Due: Rolling through October 6, 2020
  • Project period: Up to 2 years
  • Purpose: To investigate stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.
Notice of Special Interest: Administrative Supplements & Competitive Revision Supplements on COVID-19 Within Mission of NIAAA
  • Due: Rolling through April 15, 2021
  • Funding: Up to $100,000 per year; exceptions require permission
  • Project period: Up to 2 years
  • Purpose: To understand relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic.

National Institute on Drug Abuse (NIDA)

Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions for Research on COVID-19
  • Due: Rolling until April 1, 2021
  • Funding: $100,000 per year
  • Project period: 2 years
  • Purpose: To support research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

National Library of Medicine (NLM)

Notice of Special Interest: Data Driven Research on Coronavirus Disease 2019 (R21)
  • Due: June 16, 2020
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To foster data-driven research, NLM requests R21 applications to address: 1) methods for mining clinical data to identify or predict presence of COVID-19 in biomedical phenotype data, or other relevant topics; 2) public health surveillance methods to identify spread and impact of SARS-Cov-2.

Other Federal Funding Opportunities:

Agency for Healthcare Research and Quality

Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)
  • Due: June 15, 2020
  • Funding: Up to $1M total costs (up to $500,000 per year)
  • Project period: Up to two years
  • Purpose: To fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality, safety, and value of health system response to COVID-19, and the role of primary care practices and professionals during the COVID-19 epidemic.

Biomedical Advanced Research & Development Authority

Broad Agency Announcement
  • Due: Rolling through October 31, 2020
  • Funding: Negotiated
  • Purpose: To explore the development of new medical countermeasures and take other actions to enhance health security in partnership with the U.S. Department of Health and Human Services and the Office of the Assistant Secretary for Preparedness and Response.
  • Additional information about BARDA
Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement
  • Due: Rolling through February 3, 2023
  • Funding: Negotiated
  • Purpose: To fund COVID-19 related research in the development of diagnostics and/or vaccines.

Department of Defense 

Clinical Trial Award for Emerging Viral Diseases and Respiratory Health
  • Pre-application due: June 8, 2020
  • Application due: June 22, 2020
  • Funding: Not specified ($30 million for 5 awards)
  • Funding period: 4 years
  • Purpose: To address at least one of the FY20 PRMRP Topic Areas of Emerging Viral Diseases and Respiratory Health related to COVID-19.
Investigator-Initiated Research Award (for Emerging Viral Diseases and Respiratory Health)
  • Pre-application due: May 28, 2020
  • Application due: June 12, 2020
  • Funding: $1.6M (single PI) to $2.0M (partnering PI) direct costs
  • Project period: 4 years
  • Purpose: To support research with the potential to yield highly impactful data that could lead to critical discoveries or major advancements.
Technology/Therapeutic Development Award (for Emerging Viral Diseases and Respiratory Health)
  • Letter of intent due: May 28, 2020
  • Application due: June 12, 2020
  • Funding: Maximum of $4.0 M direct costs
  • Project period: 4 years
  • Purpose: To provide support for the translation of promising preclinical findings into products for clinical applications.

Department of Energy

Invitation to send research questions
  • Due: Rolling review
  • Purpose: To identify scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.

Department of State

COVID-19 Small Grants Program
  • Due: September 30, 2020
  • Funding: $100,000
  • Purpose: To strengthen and expand U.S.-India collaboration in fighting COVID-19. 
Countering Corruption Amid COVID-19
  • Due: June 12, 2020
  • Funding: $1M
  • Project period: 2 to 3 years
  • Purpose: To fund 1 project to enhance transparency and empower civil society and media to monitor and promote accountability of government responses to COVID-19.

Department of the Air Force

CSO_COVID_19 Response
  • Due: September 30, 2020
  • Purpose: To focus on four primary lines of effort: 1) Relief for external assistance requirements; 2) Resilience for Defense Industrial Base Efforts; 3) Recovery for consolidating funding requests that minimize program impacts; and 4) Rapid solicitation and execution of large-scale rapid small business contracts across all lines of effort. 

Department of the Army

Investigator-Initiated Research Award (Emerging Viral Diseases and Respiratory Health)
  • Letter of intent due: May 28, 2020
  • Application due: June 12, 2020
  • Funding: $1.6M (single PI) to $2.0M (partnering PI) direct costs
  • Project period: 4 years
  • Purpose: To support research with the potential to yield highly impactful data that could lead to critical discoveries or major advancements.
Technology/Therapeutic Development Award (Emerging Viral Diseases and Respiratory Health)
  • Letter of intent due: May 28, 2020
  • Application due: June 12, 2020
  • Funding: Maximum of $4.0 M direct costs
  • Project period: 4 years
  • Purpose: To provide support for the translation of promising preclinical findings into products for clinical applications.
Clinical Trial Award for Emerging Viral Diseases and Respiratory Health
  • Due: June 22, 2020
  • Funding: Negotiated
  • Project period: Not specified
  • Purpose: To support rapid implementation of clinical trials with the potential to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies.

Environmental Protection Agency

Removal Emergency Response Program
  • Due: June 10, 2020
  • Funding: up to $100,000 per year
  • Project period: up to 5 years
  • Purpose: To promote the participation of individual State and territorial programs in research activities with the mission of advocating for and supporting State emergency response readiness and removal program planning and preparedness.

National Institute of Standards & Technology

NIST Manufacturing USA National Emergency Assistance Program
  • Due: Rolling review
  • Funding: $250,000 to $10 million
  • Project period: Not specified
  • Purpose: To invite Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic. Several project areas are listed.

National Science Foundation

Ecology and Evolution of Infectious Diseases
  • Due: November 18, 2020
  • Funding: Up to $2.5 million total
  • Project period: 5 years
  • Purpose: To support research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases.
RAPID Funding Mechanism for COVID-19 Related Investigations
  • Due: follow application type
  • Funding: up to $200,000 via RAPID
  • Project period: up to 1 year via RAPID
  • Purpose: To encourage submissions to existing opportunities via the RAPID funding mechanism for COVID-19-related investigations.

NSF – Office of Advanced Cyberinfrastructure 

Provisioning Advanced Cyberinfrastructure to Further Research on COVID-19
  • Due: Rolling
  • Funding: Not specified
  • Purpose: To invite RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

Patient-Centered Outcomes Research Institute

Applicant and awardee FAQs for COVID-19 projects.
COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects
  • Due: Rolling
  • Funding: up to $500,000 total costs
  • Project period: enhancement may extend original period up to 1 year
  • Purpose: To enhance existing research awards that can be initiated quickly to influence the outcome of the current pandemic and that have some relationship to the original award, using existing teams that are currently funded by PCORI.
COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards
  • Due: Rolling
  • Funding: up to $150,000 total costs
  • Project period: enhancement may extend original period up to 1 year
  • Purpose:  To enhance existing Engagement Awards that can be initiated sufficiently quickly to influence the outcome of the current pandemic by using existing teams that are currently funded by PCORI. 
COVID-19-Related Enhancements to Existing PCORI-Funded Dissemination and Implementation Awards
  • Due: Rolling
  • Funding: Up to $500,000 total costs
  • Project period: May not extend current project more than 12 months
  • Purpose: To enhance existing Dissemination and Implementation awards can be initiated quickly to mitigate the outcome of the current pandemic by using existing teams with ongoing working relationships with PCORI.
PCORI Broad & Methods PFAs
  • Due: May defer submission to September 1, 2020 (Cycle 2)
  • Deferral requests due: May 5

US Department of Agriculture

Distance Learning and Telemedicine Grants
  • Due: July 13, 2020
  • Funding: Up to $1M
  • Purpose: To enable and improve distance learning and telemedicine services in rural areas to increase access to education, training, and health care resources. Relevance to COVID-19 is encouraged.

US Food and Drug Administration

FDA Postgraduate COVID-19 Analysis Fellowship
  • Due: September 24, 2020
  • Funding: Not specified
  • Project period: 1 year with opportunity for renewal
  • Purpose: To provide training in computer science, bioinformatics, and/or computational biology. Most projects have a component of machine learning and the participant will learn to use these on large biological datasets, including RNA-seq. The participant will be learning bioinformatics tools to answer questions such as, translation rate of viral and host genes, analysis of polymorphisms in the population that may have predisposition to get infected, sequence analysis to design vaccine, optimization and de-optimization of viral sequences.

Veterans Affairs

Health Services Research & Development Rapid Projects for Time-Sensitive Topics: COVID-19
  • Due: Rolling through July 1, 2020; reviewed monthly *Hold on applications until June 15
  • Funding: Not specified
  • Project period: Up to 9 months
  • Purpose: To build partnerships, develop capacity, and conduct the foundational research and operations work necessary to address critical questions surrounding the COVID-19 outbreak.

Non-Federal Opportunities & Consortia:

23andMe

COVID-19 Study
  • Due: Open
  • Purpose: To uncover genetic risks associated with severe outcomes of infections by SARS-CoV-2.
  • Note: Soliciting participation in a collaborative study. Contact information provided for investigators who would like to partner with 23andMe.

Amazon Web Services

AWS Diagnostic Development Initiative
  • Due: June 30, 2020
  • Support: Technical consultation with AWS promotional credits
  • Project Period: Not specified
  • Purpose: To provide support for innovation in patient testing for COVID-19 and other diagnostic solutions to mitigate future outbreaks.

American Thoracic Society

ATS/CHEST Foundation Research Grant in Diversity
  • Due: June 23, 2020
  • Funding: $40,000
  • Project period: 2 years
  • Purpose: To fund clinical research that contributes to the understanding of the pathophysiology or treatment of conditions related to pulmonary, critical care, or sleep medicine that disproportionately affects URM patient groups. The grant is not specific to COVID-19, but it may be of interest to researchers interested in addressing the pandemic’s health effects in communities of underrepresented minorities.
  • Eligibility notes: At least one key personnel must be an ATS member at the time of application.
ATS/GSK Research Grant in COVID-19
  • Due: June 23, 2020
  • Funding: $50,000
  • Project period: 1 year
  • Purpose: To fund Asst. Professors conducting research in COVID-19.

Berytech Fab Lab

HealthTech Solutions Initiative: Prototyping Solutions for the Coronavirus Crisis
  • Due: Open
  • Funding: $10,000 for prototyping
  • Project period: Not specified
  • Purpose: To support teams working on a health technology solution including test kits, respiratory devices, protective equipment or mobile applications for detection, tracing, and information sharing, that can respond immediately to the coronavirus crisis and the current emergency medical needs for Lebanon.

Biogen

COVID-19 Relief
  • Due: Open
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To provide relief focused on the following categories: 1) Expanding and ensuring access to testing, 2) Easing the burden on healthcare systems and healthcare workers, 3) Providing food and necessities for our most vulnerable populations
  • Eligibility Notes: Must be a 501(c)3 organization

Business Finland

Temporary Co-Creation Funding Service
  • Due: June 30, 2020
  • Funding: €300,000 (Business Finland covers 80% of eligible costs up to this amount)
  • Project period: Six months
  • Purpose: Temporary funding for solutions related to solutions that help in the corona crisis and renewal of industries (e.g. tourism, consumer business and health. The projects to be funded must be closely linked to tackling the challenges caused by the corona crisis and to commercializing the solutions in a changing world.

California Health Care Foundation

Unsolicited requests – Letter of Inquiry
  • Due: Open
  • Funding: Not specified
  • Purpose: To advance improvements in the health care delivery system for the people of California, particularly those with low incomes and those whose needs are not well served by the status quo.

California Institute for Regenerative Medicine

Special Call for COVID-19 Projects
  • Due: Every 2 weeks, starting April 7, 2020
  • Funding: $150,000 to $750,000, depending on study type
  • Project period: 12 to 24 months, depending on study type
  • Purpose: To support promising discovery, preclinical and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need.

Coalition for Epidemic Preparedness Innovation (CEPI)

Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19
  • Due: Rolling through June 30, 2020
  • Funding: Not specified
  • Purpose: To support rapid development of vaccines striving for licensure/emergency authorization in 12-18 months or less and, to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021.
  • Notes: The applicant should either be a manufacturer or have a manufacturer with a track record of vaccine production identified within the consortium.

COVID-19 Early Treatment Fund

Grants Program
  • Due: Open
  • Funding: Not specified
  • Purpose: To support initiatives that focus on treating outpatients to prevent hospitalization.

Donaghue Foundation

Greater Value Portfolio Grant Program
  • Letter of Intent: May 11, 2020 (Decision: June 8, 2020)
  • Due: August 3, 2020
  • Funding: Up to $400,000
  • Project period: 2 years
  • Purpose: To advance promising approaches to achieve a higher value healthcare system. Goal of this program is to test approaches and tools organizations can readily use to improve the value of the healthcare they provide to their patients and communities. Research questions related to our nation’s response to the COVID-19 pandemic could fit within this topic.

Draper Richards Kaplan Foundation

Coronavirus Urgent Response Initiative
  • Due: Open
  • Funding: Negotiated
  • Project Period: Able to deploy within 30 days
  • Purpose: To find, fund, and support the people and ideas that are tackling the most acute and time-critical social problems caused by the Covid-19 pandemic right now.

EASI Genomics

Extraordinary Call for Proposals for Access Projects related to the COVID-19 crisis
  • Due: Rolling through June 30, 2020
  • Support: Providing genetic analysis
  • Project period: Not specified
  • Purpose: To support whole-genome (short- and/or long-read), whole exome, and RNA sequencing of human patients from low-risk populations with severe forms of SARS-Cov-2 infection that have experienced adverse reactions or fatal outcomes.

Extreme Science and Engineering Discovery Environment (XSEDE)

COVID-19 HPC Consortium
  • Due: Rolling
  • Resources: Access to computing capabilities from some of the most powerful and advanced computers in the world
  • Purpose: To empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections via exceptional computational resources and collaborations. 
  • Eligibility Notes: 3 page application must describe need for high-performance computing and have high-performance computing knowledge and experience on the proposing team

Ferring Pharmaceuticals

COVID-19 Investigational Grants in Reproductive Medicine & Maternal Health
  • Due: April 15, 2020 until October 31, 2020
  • Funding: 25,000 EURO
  • Purpose: To fund exploratory, basic, and clinical research grants to collect data and expand knowledge on the effects of COVID-19 on reproduction, pregnancy and neonatal health. The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic.

Gates Foundation

No open requests for investigator-initiated applications related to COVID-19 are available at this time. Current funding is directed to the COVID-19 Therapeutics Accelerator in collaboration with Wellcome and Mastercard, as well as targeted international efforts.

Islamic World Educational, Scientific, and Cultural Organization

ICESCO Prize for Fighting Against Coronavirus
  • Due: Nominations open
  • Funding: $200,000
  • Purpose: To reward independent researcher, group of researchers, or institution for discovering effective cure or vaccine against the novel Coronavirus

Medical Technology Enterprise Consortium

Interoperable Medical Automated Systems (iMAS) Technology and Gap Assessment
  • Due: June 18, 2020
  • Funding: Negotiated
  • Project period: Up to 5 years
  • Purpose: To help develop a research prototype for the ability to tele-monitor and capture research data for the following research areas: 1) COVID-19 wards, 2) emergency rooms/trauma rooms (ERs/TRs), and 3) neurological patients.

Merck KgaA

Research Grant for Pandemic Preparedness
  • Due: Rolling
  • Funding: Up to 500,000 EURO per year
  • Project period: 3 years
  • Purpose: To leverage technological solutions to be more prepared for pandemic outbreaks or solutions that could help to fight emerging viral infections.

Microsoft

AI for Health for COVID-19
  • Due: June 15, 2020
  • Purpose: To provide Azure cloud and High-Performance Computing services. Our team of AI for Health data science experts, whose mission is to improve the health of people and communities worldwide, is also open to collaborations with COVID-19 researchers. More broadly, Microsoft’s research scientists across the world, spanning computer science, biology, medicine, and public health, will be available to provide advice and collaborate per mutual interest. 

Mosaic

COVID-19 Rapid Response Infrastructure RFP
  • Due: May 22, 2020; June 12, 2020; July 2, 2020
  • Funding: Up to $10,000 or $50,000, depending on grant type
  • Project period: Not specified
  • Purpose: To support individual nonprofit grassroots organizations, and networks of them, focused primarily on environmental protection and/or environmental justice to fund tools & technology, training, and related resources needed as a result of the COVID-19 pandemic.
  • Eligibility Notes: Must be non-profit organization or a grassroots network.

Mozilla

Mozilla Open Source Support (MOSS)
  • Due: Rolling with monthly review
  • Funding: $5,000 to $150,000
  • Purpose: To support open source projects creatively responding to the COVID-19 pandemic. Includes but is not limited to software, hardware, firmware, design, and networking projects. All projects must generally involve some amount of technical development.
  • Note: Some tracks have been suspended due to high application volume. Secure Open Source Fund nominations remain open.

NORCAL Group Foundation

COVID-19 Relief & Response Campaign
  • Due: Rolling through July 31, 2020 *temporarily suspended thru 6/15 for review of initial submissions
  • Funding: Up to $10,000
  • Project period: Not specified
  • Purpose: To award specific grants that support COVID-19 Relief and Response for non-profits who serve the healthcare community in areas of: 1) virtual telehealth, 2) caregiver counseling, or 3) protective equipment.

North American Thrombosis Forum

COVID-19 and Thrombosis Grant Information
  • Due: June 24, 2020
  • Funding: $25,000 direct costs
  • Project period: 9 to 12 months
  • Purpose: To support thrombosis-focused applicants who will contribute to understanding the pathogenesis, diagnosis, prevention, treatment, and management (including critical care management) of COVID-19-associated thrombosis.
  • Eligibility Notes: 1) Candidate must hold Ph.D. degree or equivalent, or a doctoral- level clinical degree; 2) Applicants must be within 5 years of completing the ultimate stage of training; 3) Candidate must be a US Citizen or Green Card holder.

Nurses House

COVID-19 Emergency Assistance
  • Due: July 31, 2020
  • Funding: $1,000
  • Project period: Not specified
  • Purpose: To provide short term grants to nurses who are unable to work due to medical crisis. Assistance provided helps cover basic needs such as rent or mortgage payments or medical expenses. Furloughed nurses are not eligible.

One Young World

COVID-19 Young Leaders Fund
  • Due: Open
  • Funding: 2,500 to 10,000 pounds
  • Project period: Not specified
  • Purpose: To support young leaders who are tackling the Covid-19 pandemic on the frontlines.

Open Road Alliance

Charitable grants and loans in response to COVID-19
  • Due: Open
  • Funding: Not specified
  • Project Period: Not specified
  • Purpose: To support organizations responding directly to COVID-19 that also demonstrate how their intervention moves towards longer term adaptation and systemic/sustainable impact beyond the immediate outbreak. Not research-related.
  • Eligibility Note: Must be non-profit or registered charity.

Paul Scherrer Institut (Swiss)

Priority access call for work on combating COVID-19
  • Due: Rolling through September 2020
  • Funding: Not specified
  • Project period: Rapid launch, unspecified
  • Purpose: To contribute to the understanding of the virus and/or to improve the clinical or public health response and patient care. Explicitly requires projects that can launch within months
  • Notes: Short proposal, rapid review. Requires DUO or PSI ID numbers. Links available to obtain.

Pfizer

Providing Enhanced Medical Support for Patients with Primary Immunodeficiency
  • Due: June 8, 2020
  • Funding: Up to $250,000
  • Purpose: To support patient-focused programs that help patients and providers address the heightened medical and educational needs of patients with primary immunodeficiency during this pandemic.
Vaccine Preventable Diseases – COVID-19
  • Due: Rolling through June 17,2020
  • Funding: $50,000 to $250,000
  • Project period: Not specified
  • Purpose: To increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. Particularly: 1) tnderstand impact of COVID on communities, spectrum of disease in communities, and level of herd immunity; 2) postmortem Analysis of deceased persons with known or suspected COVID-19
2020 Osteoarthritis & Osteoarthritis Pain – Virtual Learning Competitive Grant Program
  • Due: July 22, 2020
  • Funding: Up to $250,000
  • Purpose: To support virtual programs for HCPs on Osteoarthritis and Chronic Pain associated with OA patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, the impacts of COVID-19 on chronic pain osteoarthritis patients, and the future of OA/OA pain management.

PurSolutions

Cytoskeleton Reagent Scholarship
  • Due: Rolling, rapid review
  • Funding: Free reagents
  • Project period: Not specified, research ready to launch
  • Purpose: To provide cytoskeleton reagents for COVID research. Coronavirus spike proteins interact with cytoskeleton filaments (i.e. microtubules and actin) for internalization into host cells – a critical step in viral pathogenesis. For some coronaviruses that targeting the cytoskeleton with tubulin or actin inhibitors reduces viral load
  • Eligibility Note: Application includes all career stages from graduate students to PIs. Brief <=5,000 character, online submission to request free reagents for COVID research.

Regional Studies Association

Small Grant Scheme on Pandemics, Cities, Regions & Industry
  • Due: June 22, 2020
  • Funding: Up to $5,000 (4,000 pounds)
  • Project period: Up to 9 months
  • Purpose: To support a discrete piece of regional studies and/or regional science research on the impact of the Coronavirus (COVID-19) on regions cities and industry.
  • Eligibility Notes: Must be based at eligible higher education institution (HEI) and must be a current individual (non-corporate) member of the Regional Studies Association and remain a member throughout the duration of the grant and reporting period.

Rheumatology Research Foundation

Notice of Special Interest
  • Letter of Intent due: June 1, 2020
  • Application due: July 1, 2020 or August 3, 2020 (depending on award)
  • Funding: $225,000 to $400,000 (depending on award)
  • Project period: 2 to 3 years (depending on award)
  • Purpose: To explore the relationship between rheumatic and musculoskeletal diseases and SARS-CoV-2.
  • Eligibility Notes: Varies by award

Robert Wood Johnson Foundation

Pioneering Ideas: Exploring the Future to Build a Culture of Health
  • Due: Open
  • Funding: Not specified
  • Project period: Flexible, typically 1 to 3 years
  • Purpose: To address four areas of focus: 1) future of evidence; 2) future of social interaction; 3) future of food; 5) future of work. Proposals may choose to focus on COVID-19, directly or indirectly, but a response to the pandemic is not required.

Social Science Research Council

Social Data Research Fellowship – COVID-19 focus
  • Due: June 16, 2020
  • Funding: Up to $50,000
  • Project period: Up to 12 months
  • Purpose: To encourage applications that investigate the impact of the coronavirus pandemic as it intersects with the core themes, including social media and the 2020 elections.
  • Eligibility Notes: Open to researchers who hold a PhD in a relevant discipline and are based at an institution of higher education (college or university) or a non-profit focused on social research.
Social Data Dissertation Fellowship – COVID-19 focus
  • Due: June 16, 2020
  • Funding: Up to $15,000
  • Project period: Up to 12 months
  • Purpose: To encourage applications that investigate the impact of the coronavirus pandemic as it intersects with the core themes, including social media and the 2020 elections.
  • Eligibility Notes: Open to PhD students actively enrolled in a PhD program. Applicants should have completed all PhD coursework by the beginning of the fellowship term.

Spencer Foundation

Research Grants on Education: COVID-19 Related Special Grant
  • Due: May 4, May 18, June 8, 2020
  • Funding: $50,000
  • Project period: 3 years
  • Purpose: To understand the rapid shifts in education in this time of crisis and change. Specifically, 1) to understand and disrupt the reproduction and deepening of educational inequality caused by the COVID-19 crisis and 2) to re-imagine educational opportunities in these times.

Stevens Initiative

Coronavirus Response Fund
  • Due: June 12, 2020
  • Funding: $20,000 to $100,000
  • Project period: 1 year
  • Purpose: To provide resources to help education, exchange, and non-profit organizations in the United States and the Middle East and North Africa conduct virtual exchange programs to engage young people and educators affected by the pandemic.

The Global Fund

COVID-19 Response Mechanism
  • Due: May 31, 2020, or as soon as possible thereafter
  • Funding: Up to 10% of current Global Fund funding
  • Project period: Within current 2020-2022 allocation window
  • Purpose: To support countries in responding to COVID-19, mitigating the impact on programs to fight HIV, TB and malaria, and initiating urgent improvements in health and community systems.

Turkish Philanthropy Funds

TPF COVID-19 Community Relief Fund
  • Due: Rolling
  • Funding: Not specified
  • Project period: Not specified
  • Purpose: To support containment, response and recovery activities for those affected and for the responders.
  • Eligibility Notes: Currently only accepting proposals from TPF partners in Turkey. However, non-profit organizations in the US may email irem@tpfund.org to request consideration.

United States – Israel Binational Science Foundation

BSF Annual Research Grant
  • Due: Mid-November
  • Funding: $230,000
  • Project period: 3 years
  • Purpose: To support collaborative research by US and Israeli research teams in the areas of biomedical engineering, life sciences, medicine, psychobiology, exact physical sciences, and social sciences. Proposals related to COVID-19 in these priority areas are welcome.
  • Eligibility Notes: Applications made jointly by US and Israeli researchers. Prior collaboration not required.

Volkswagon Foundation

Corona Crisis and Beyond
  • Due: June 4, 2020 for new grants; Rolling for supplements to existing grants
  • Funding: Up to 120,000 euros
  • Project period: Up to 18 months
  • Purpose: To fund projects from any discipline that not only contribute directly to overcoming the crisis, but can also provide impetus for overcoming major societal challenges in the medium to long term.
  • Eligibility Notes: Open to postdoctoral researchers or professors in Germany; single or integrative joint projects (up to 3 partners), international collaborations possible.

West Coast Consortium for Technology & Innovation in Pediatrics

2020 COVID-19 Flex Grants
  • Due: Open
  • Funding: $15,000
  • Purpose: To support pediatric medical device innovators who are able to use their technology to aid in the current COVID-19 pandemic.

Challenges & Innovation Accelerator Competitions

Data.org

Inclusive Growth & Recovery Challenge
  • Due: July 17, 2020
  • Prize: data science talent, software, training, and funding from $10K up to $10 million in a mix of grant and program support
  • Project period: Not specified
  • Purpose: To award breakthrough ideas that harness the power of data science to help people and communities thrive especially in the wake of COVID-19’s economic impact.

The Elevate Prize Foundation

Elevate Prize
  • Nominations Due: June 29, 2020
  • Prize: Minimum of $300,000
  • Funding period: 2 years
  • Purpose: To award up to $5 million to multiple Global Heroes, as well as offer valuable resources for two years after being selected, helping amplify their work and build a massive movement to galvanize people all over the world to do good in their own community. As the coronavirus (COVID-19) pandemic continues to impact our lives, The Elevate Prize Foundation recognizes that there are heroes all over the world who are putting their health and safety at risk to treat those infected and save lives. Now more than ever, it is critical to recognize and uplift those who are elevating humanity by preparing for, detecting, and responding to emerging pandemics and health security threats. 
  • Eligibility Notes: Applicants with a demonstrated history of catalyzing social and/or environmental impact through their work and leadership. Looking for people with enormous energy, talent, open hearts, and open minds – who have the potential to greatly expand their reach, inspire the hearts and minds of others, and contribute to elevating humanity on a global scale.

IBM

2020 Call for Code Global Challenge: COVID-19
  • Early Judging Deadline: April 27, 2020
  • Due: July 31, 2020
  • Grand Prize: $200,000 (also 1st to 4th place cash awards)
  • Purpose: To spur innovators to create practical, effective, and high-quality applications based on one or more IBM Cloud™ services (e.g., web, mobile, data, analytics, AI, IoT, or weather) that can have an immediate and lasting impact on humanitarian issues such as the COVID-19 pandemic.
  • Eligibility Notes: University Edition of the Call for Code is available for student teams.
2020 COVID-19 Call for Code Global Challenge (herox)
  • Due: July 31, 2020
  • Award: $270,000
  • Project period: Not specified
  • Purpose: To build a coding solution that can provide immediate crisis communication, enhanced remote education, or stronger community operation.

InnoCentive

(Use this link for new challenges added often.)
InnoCentive: Gamification to Prevent the Spread of Coronavirus
  • Due: June 12, 2020
  • Award: $250 to $1,000
  • Purpose: To apply gamification to changing people’s social behavior so that to prevent the spread of Coronavirus and other infections. This is an Ideation Challenge.
InnoCentive: Anti-COVID-19 Infection Protective Film
  • Due: June 15, 2020
  • Award: $1,000
  • Purpose: To propose a thin film that, when applied to hands and other open parts of the human body, would prevent people from being infected with the COVID-19 virus. This Theoretical Challenge requires only a written proposal.
InnoCentive: What Are the Most Useful Solutions or Services People Are Offering in Support of Those Impacted by COVID-19?
  • Due: June 26, 2020
  • Award: $2,500
  • Purpose: To share detailed examples of any solutions or services they have seen offered by individuals or companies in response to the global Coronavirus pandemic.

Joint European Disruptive Initiative

Billion Molecules Against COVID-19 JEDI Grand Challenge
  • Due: Stage 1 – June 6, 2020
  • Award: 250,000 euros
  • Purpose: To rapidly identify molecules/peptides/proteins that can block the development and/or spreading of the 2019 Novel Coronavirus (SARS-CoV-2) and stop Covid-19 related disease.
  • Note: There are 3 stages. Teams can participate in one or many.

Kaggle Challenges

(Use this link for new challenges added often.)
COVID-19 Open Research Dataset Challenge (CORD-19)
  • Due: Round 1: April 16, 2020; Round 2: June 16, 2020
  • Award: Pure Satisfaction & Bragging Rights
  • Purpose: To use NLP to answer key questions from the scientific literature about COVID-19. “This challenge includes over 51,000 scholarly articles about COVID-19 and related coronaviruses and was proposed by White House Office of Science and Technology Policy and other partner institutions”
UNCOVER COVID-19 Challenge
  • Due: Ongoing
  • Award: Pure Satisfaction & Bragging Rights
  • Purpose: To collaborate with the Roche Data Science Coalition (RDSC) AI community to fight COVID-19. This challenge presents a curated collection of datasets from 20 global sources and seeks modeling solutions to key questions developed and evaluated by a global frontline of healthcare providers, hospitals, suppliers, and policy makers.

MIT Solve 

Good Jobs & Inclusive Entrepreneurship
Health Security & Pandemics
Learning for Girls & Women
Maternal & Newborn Health
Sustainable Food Systems
  • Due: June 18, 2020 for each challenge
  • Award: $10,000 for each challenge
  • Purpose: To find technology-based solutions to 1) spur good jobs; 2) slow and track spread of illness; 3) level the playing field for young women; 4) promote well-being of women, new mothers, newborns; and 5) create a low-carbon food system. Responses to COVID-19 welcome.

Robert Wood Johnson Foundation

Emergency Response for the Healthcare System Innovation Challenge
  • Due: June 12, 2020
  • Award: Semifinalists: $1,000 to develop technology; Finalists: $5,000 to $25,000 plus opportunity to pitch and demo technology to investors
  • Purpose: To create a digital tool supporting the healthcare system during a large-scale health crisis.

United Nations Development Programme Centre for Technology, Innovation and Sustainable Development

The COVID-19 Detect and Protect Challenge
  • Due: June 30, 2020
  • Award: Amazon credits and computer gear
  • Purpose: To support developing countries through the sharing and transfer of open source technology. Three priority actions: 1) design replicable, low-cost tools and resources to aid viral detection; 2) flatten the curve in communities with preventive solutions; 3) reduce the disease’s impact on the economies of these vulnerable areas.

Other Coronavirus Funding Compilations

See live links in the directory at the top of this post.

For details about the funding sources and compilations for which we conduct scheduled surveillance for funding opportunities, this is the working document enumerating sources and links: bit.ly/34HBOt8

Pardon the dust: these resources are always under construction and not all fields may be complete, with a priority on link accuracy.

Please suggest additions of funding opportunities in comments.

Want to live on the Edge?

Register


Join the conversation

Your email address will not be published. Required fields are marked *


Saving subscription status...

0 Comments

You May Also Like